THYROCARE TECHNOLOGIES
Back to Cashflow Statement
|
THYROCARE TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-130 Cr | ₹-85 Cr | ₹-86 Cr | ₹-89 Cr | ₹-62 Cr |
What is the latest Cash Flow from Financing Activities ratio of THYROCARE TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-130 Cr |
| Mar2024 | ₹-85 Cr |
| Mar2023 | ₹-86 Cr |
| Mar2022 | ₹-89 Cr |
| Mar2021 | ₹-62 Cr |
How is Cash Flow from Financing Activities of THYROCARE TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-130 Cr | Negative | |
| Mar2024 | ₹-85 Cr | Negative | |
| Mar2023 | ₹-86 Cr | Negative | |
| Mar2022 | ₹-89 Cr | Negative | |
| Mar2021 | ₹-62 Cr | - | |
Compare Cash Flow from Financing Activities of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹8,356.4 Cr | 2.5% | 24.6% | 54.9% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹119,105.0 Cr | 0.1% | 7.1% | 16.5% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹93,966.7 Cr | -3% | -4.5% | -17.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹70,218.7 Cr | -3.2% | -2.4% | 30.8% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹40,491.0 Cr | 3.2% | 10.6% | 12.3% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹37,796.9 Cr | -1.6% | -2% | 34% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | 2.5% |
24.6% |
54.9% |
| SENSEX | -2.2% |
-3.3% |
-8.8% |
You may also like the below Video Courses